Veracyte (VCYT) CFO Rebecca Chambers Sells Shares

What Happened
Rebecca Chambers, Veracyte's Chief Financial Officer, disposed of stock in two open‑market transactions on June 4, 2026, selling a total of 3,561 shares for aggregate proceeds of approximately $177,083 (1,600 shares at a weighted avg. $49.28 for $78,854; 1,961 shares at a weighted avg. $50.09 for $98,229). Separately, on June 2, 2026, 3,693 shares were withheld to satisfy tax withholding obligations related to the vesting of restricted stock units; that withholding does not represent a sale and generated estimated value of $176,525 at $47.80 per share.

Key Details

• Transaction dates: June 2, 2026 (tax withholding), June 4, 2026 (open‑market sales).
• Open‑market sale totals: 3,561 shares sold for ~$177,083 in proceeds.
• Tax withholding: 3,693 shares withheld to satisfy tax on vested RSUs (not a sale), valued at $176,525.
• Prices and notes: 1,600 shares reported at $49.28 (F3 weighted avg; actual prices ranged $48.80–$49.74); 1,961 shares reported at $50.09 (F4 weighted avg; actual prices ranged $49.88–$50.40).
• Plan/authorization: Sales were made pursuant to a Rule 10b5‑1 trading plan adopted August 21, 2025 (F2).
• Shares owned after transaction: Not disclosed in the Form 4 filing.
• Filing timeliness: Form 4 filed June 4, 2026; filing appears timely based on reported dates.

Context
The June 2 entry reflects share withholding to cover taxes on RSU vesting (a common non‑market transaction), while the June 4 transactions were open‑market sales executed under a pre‑arranged 10b5‑1 plan. Sales by executives can be routine (e.g., tax withholding or planned disposals) and do not by themselves indicate a change in company outlook.